PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsNeuralgia
MeSH D009437 - neuralgia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010146:Pain
$
Success rate
D010523:Peripheral nervous system diseases
0 Companies
0 Drugs
Success rate
D009437: 
Neuralgia
$
Success rate
D000070607:Morton neuroma
0 Companies
0 Drugs
Success rate
D012585:Sciatica
0 Companies
0 Drugs
Success rate
D051474:Postherpetic neuralgia
$
Success rate
D055958:Piriformis muscle syndrome
0 Companies
0 Drugs
Success rate
D060545:Pudendal neuralgia
0 Companies
0 Drugs
Success rate
D002422:Causalgia
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaClonazepam Clonazepam  1996-09-10   
MylanClonazepam Clonazepam  1997-10-30   
Duloxetine Duloxetine Mylan  2015-06-19   
Pregabalin Pregabalin Mylan Pharma  2015-06-25   
RocheClonazepam Klonopin Rapidly Disintegrating  1997-12-23   
SandozClonazepam Clonazepam  1997-08-29   
Pregabalin Pregabalin Sandoz  2015-06-19   
Eli LillyDuloxetine Duloxetine Lilly  2014-12-08   
Aurobindo PharmaClonazepam Clonazepam  1998-10-05   
Barr PharmaceuticalsClonazepam Clonazepam  2005-08-10   
Sun Pharmaceutical IndustriesClonazepam Clonazepam  2001-04-27   
Alembic PharmaceuticalsClonazepam Clonazepam  2019-06-28   
Prinston PharmaceuticalClonazepam Clonazepam  2006-06-28   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
78%
21/27
Phase 2
45%
34/76
Phase 3
65%
28/43
Approved: 5Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Eli Lilly
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use